#

Applicant

Investment

1

ProTA Therapeutics Pty Ltd (OneVentures Healthcare Fund III)

OneVentures Healthcare Fund III has committed $10 million to ProTA Therapeutics to advance the development of a promising new treatments of food allergies in children and adults.

 2

Rex Bionics (BioScience Managers Translation Fund 1)

BioScience Managers Translation Fund 1 has invested $11 million to Rex Bionics to develop a hands-free robotic device to help people with severe disability to walk, exercise and rehabilitate.

3 Saluda Medical (BioScience Managers Translation Fund 1) BioScience Managers Translation Fund 1 has invested $3.3 million to Saluda Medical for neuromodulation technologies for people suffering from chronic back pain and other debilitating conditions.
4 SummatiX Pty Ltd (BioScience Managers Translation Fund 1)
BioScience Managers Translation Fund 1 has committed $10 million to SummatiX Pty Ltd for data aggregation and commercialisation services for makers of 'smart' medical devices.
Global Kinetics Corporation (MRCF-BTF Fund and BioScience Managers Translation Fund 1)
Brandon Capital Partners' MRCF BTF Fund and BioScience Managers Translation Fund 1 has committed $18 million to Global Kinetics Corporation to accelerate the development and commercialisation of a wrist-worn device that measures symptoms and provides clinical reports to assist with planning routine care for Parkinson's patients.
6 BiVACOR Pty Ltd (OneVentures Healthcare Fund III)
OneVentures Healthcare Fund III has invested $9.7 million to BiVACOR, a company that is developing a rotary total artificial heart device that could provide a life-saving solution for individuals requiring a new heart.
7 Avita Medical Ltd (BioScience Managers Translation Fund 1)
BioScience Managers Translation Fund 1 has invested $6.5 million to Avita Medical Ltd for improved skin regeneration through a unique process using the patient's own skin.
8 Aravax Pty Ltd (MRCF-BTF Fund)
Brandon Capital Partners' MRCF BTF Fund has invested $5.59 million into Aravax Pty Ltd for a novel form of peptide immunotherapy to treat peanut allergy.
 9 GI Therapies Pty Ltd (MRCF-BTF Fund) Brandon Capital Partners' MRCF BTF Fund has invested $1.62 million to GI Therapies Pty Ltd to develop a device to treat a range of gastrointestinal motility disorders.
10  Certa Therapeutics Pty Ltd (MRCF-BTF Fund)
Brandon Capital Partners' MRCF-BTF Fund has committed $22 million to Certa Therapeutics to progress the clinical development of a drug to treat kidney disease.
11 Paragen Bio Pty Ltd (OneVentures Healthcare Fund III)
OneVentures Healthcare Fund III has committed up to $2 million to Paragen Bio Pty Ltd, a company that is developing treatments to target autoimmune diseases using the beneficial proteins found in parasitic hookworms.
12 Respirion Pharmaceuticals Pty Ltd (MRCF-BTF Fund)
Brandon Capital Partners’ MRCF-BTF Fund has committed $20 million to Respirion Pharmaceuticals Pty Ltd to fund clinical trials and product development in a new therapy for the treatment of Cystic Fibrosis.
13 Madorra Pty Ltd (OneVentures Healthcare Fund III)
OneVentures Healthcare Fund III has invested $4.06 million to Madorra Pty Ltd. The company is working towards changing the paradigm for treating vaginal dryness for post-menopausal women and breast cancer survivors, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. 
14  Blade Therapeutics Pty Ltd (OneVentures Healthcare Fund III)
OneVentures Healthcare Fund III has invested $17.2 million to Blade Therapeutics Pty Ltd to assist in the development of a drug to treat fibrosis. Fibrosis is a disease with a high morbidity rate which affects many organs, for which there is no effective treatment. It particularly affects the lungs, kidneys and liver.
 15  Denteric Pty Ltd (MRCF-BTF Fund) MRCF-BTF Fund has committed $9.23 million into Denteric Pty Ltd to assist in the development of a vaccine that will prevent severe gum disease, which is highly prevalent around the world and causes significant issues such as bone erosion and tooth loss. Severe gum disease has also been linked to many other health problems such as diabetes, heart disease, stroke and Alzheimers Disease.